The Patent Finder

Locus Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Locus Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 6 of 6 · Back to Locus Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 8,765,754Pyrrolotriazine compounds
Lapsed on the fee record
Ended Jul 1, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jul 1, 2022From the USPTO record
US 7,741,479Urea inhibitors of MAP kinases
Lapsed on the fee record
Ended Jun 22, 2014 · From the USPTO record
Lapsed on the fee recordEnded Jun 22, 2014From the USPTO record
US 7,612,200Inhibitors of protein kinases
Lapsed on the fee record
Ended Nov 3, 2013 · From the USPTO record
Lapsed on the fee recordEnded Nov 3, 2013From the USPTO record
US 7,504,401Anti-cancer agents and uses thereof
Lapsed on the fee record
Ended Mar 17, 2013 · From the USPTO record
Lapsed on the fee recordEnded Mar 17, 2013From the USPTO record
US 7,415,361Methods and systems for analyzing and determining ligand-residue interaction
Lapsed on the fee record
Ended Aug 19, 2012 · From the USPTO record
Lapsed on the fee recordEnded Aug 19, 2012From the USPTO record
US 6,182,016Molecular classification for property prediction
Formerly held
Lapsed on the fee record
Ended Jan 30, 2009 · From the USPTO record
Lapsed on the fee recordEnded Jan 30, 2009From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited